Pashtoon M. Kasi, MD, MBBS, MS | Authors

Articles

The Emerging Role of Genetic Testing in Colorectal Cancer

April 09, 2019

Pashtoon M. Kasi, MD, MBBS, MS, discusses how genetic testing is underutilized in colorectal cancer, despite its ability to guide treatment dosing and adjustment based on the mutations or variations within a patient.

Next Steps After Phase III BEACON CRC Trial in mCRC

January 19, 2019

Pashtoon M. Kasi, MD, MBBS, MS, discusses how the triplet regimen of the BRAF inhibitor encorafenib, the MEK inhibitor binimetinib, and the EGFR inhibitor cetuximab, will impact the treatment landscape for patients with metastatic colorectal cancer.